GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guanhao Biotech Co Ltd (SZSE:300238) » Definitions » Cyclically Adjusted FCF per Share

Guanhao Biotech Co (SZSE:300238) Cyclically Adjusted FCF per Share : ¥0.13 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Guanhao Biotech Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Guanhao Biotech Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was ¥-0.083. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.13 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Guanhao Biotech Co's average Cyclically Adjusted FCF Growth Rate was -7.10% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 48.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Guanhao Biotech Co was 48.10% per year. The lowest was 48.10% per year. And the median was 48.10% per year.

As of today (2024-06-20), Guanhao Biotech Co's current stock price is ¥9.22. Guanhao Biotech Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥0.13. Guanhao Biotech Co's Cyclically Adjusted Price-to-FCF of today is 70.92.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Guanhao Biotech Co was 1180.00. The lowest was 67.15. And the median was 120.11.


Guanhao Biotech Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Guanhao Biotech Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guanhao Biotech Co Cyclically Adjusted FCF per Share Chart

Guanhao Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.04 0.11 0.13 0.13

Guanhao Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.15 0.16 0.13 0.13

Competitive Comparison of Guanhao Biotech Co's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Guanhao Biotech Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guanhao Biotech Co's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Guanhao Biotech Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Guanhao Biotech Co's Cyclically Adjusted Price-to-FCF falls into.



Guanhao Biotech Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Guanhao Biotech Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.083/115.2271*115.2271
=-0.083

Current CPI (Mar. 2024) = 115.2271.

Guanhao Biotech Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.014 98.200 0.016
201409 -0.008 98.900 -0.009
201412 0.115 99.000 0.134
201503 0.017 99.900 0.020
201506 0.069 99.500 0.080
201509 0.014 100.500 0.016
201512 0.107 100.600 0.123
201603 -0.005 102.200 -0.006
201606 0.125 101.400 0.142
201609 -0.006 102.400 -0.007
201612 -0.271 102.600 -0.304
201703 -0.036 103.200 -0.040
201706 -0.148 103.100 -0.165
201709 0.074 104.100 0.082
201712 -0.121 104.500 -0.133
201803 0.040 105.300 0.044
201806 0.018 104.900 0.020
201809 0.064 106.600 0.069
201812 -0.124 106.500 -0.134
201903 -0.109 107.700 -0.117
201906 0.046 107.700 0.049
201909 0.017 109.800 0.018
201912 0.421 111.200 0.436
202003 -0.061 112.300 -0.063
202006 0.236 110.400 0.246
202009 0.088 111.700 0.091
202012 0.154 111.500 0.159
202103 0.102 112.662 0.104
202106 0.146 111.769 0.151
202109 0.075 112.215 0.077
202112 0.120 113.108 0.122
202203 0.082 114.335 0.083
202206 0.034 114.558 0.034
202209 -0.069 115.339 -0.069
202212 0.066 115.116 0.066
202303 0.010 115.116 0.010
202306 0.101 114.558 0.102
202309 0.040 115.339 0.040
202312 -0.141 114.781 -0.142
202403 -0.083 115.227 -0.083

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Guanhao Biotech Co  (SZSE:300238) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Guanhao Biotech Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=9.22/0.13
=70.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Guanhao Biotech Co was 1180.00. The lowest was 67.15. And the median was 120.11.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Guanhao Biotech Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Guanhao Biotech Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Guanhao Biotech Co (SZSE:300238) Business Description

Traded in Other Exchanges
N/A
Address
No.12 Yuyan Road, Luogang District, Guangdong, Guangzhou, CHN, 510530
Guanhao Biotech Co Ltd is a China-based biotech company. It develops, manufactures and markets life and health-related products, with focus on regenerative medicines for the treatment of damaged tissue and organs. Its products include NormalGEN dura repair patch, GrandNeuro (Type B) dura repair patch, ThromalGEN (Type P) surgical patch, Guanhao-ACI, among others.
Executives
Liu De Wang Directors, executives
Zhao Jun Hui Directors, executives
Yang Guo Sheng Supervisors
Zhu Wei Ping Director
Hu Jun Securities Affairs Representative
Jia Bao Rong Executives
Jia Jun Chao Executives
Di Pu Director
Zhuo Fu Min Director
Guo Xiao Ming Executives
Zhang Hong Tao Executives
Zhao Wen Jie Executives
Guan Xin Director

Guanhao Biotech Co (SZSE:300238) Headlines

No Headlines